Biocon Partner Secures Insulin Supply Contracts in Malaysia

Biocon Limited’s long-standing partner in Malaysia, Duopharma Biotech Berhad, has secured multiple insulin supply contracts from Malaysia’s Ministry of Health worth more than MYR 225 million, strengthening access to essential diabetes treatments in the country. The contracts cover human insulin, insulin glargine and insulin aspart, and will be supplied through Biocon’s Malaysian subsidiary, Biocon Sdn. […]